1 ONG P,SECHTEM U. Controversies in the treatment of patients with STEMI and multivessel disease: is it time for PCI of all lesions?[J]. Clin Res Cardiol,2016,105(6): 467-470. 2 MAHMO U K,NIJSTEN M W,WIERINGA W G,et al. Independent association between symptom onset time and infarct size in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Chronobiol Int,2015,32(4):468-477. 3 SOLHPOUR A,CHANG K W,BALAN P,et al. Comparison of outcomes for patients >= 75 years of age treated with Pre-Hospital Reduced-Dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-Elevation myocardial infarction[J]. Am J Cardiol,2014,113(1): 60-63. 4 彭云珠,郭涛,郑圆圆,等.急性心肌梗死患者血脂改变及其对预后的影响分析[J].重庆医学,2012,41(16):1601-1603. 5 SUZUKI M,ENOMOTO D,SEIKE F,et al. Clinical features of early myocardial rupture of acute myocardial infarction[J]. Angiology,2012,63(6): 453-456. 6 杨泽福,万建平,杨玲,等.急性心肌梗死患者无复流现象与降低血浆胆固醇的临床观察[J].临床荟萃,2013,28(3):270-272. 7 TARANTINI G,D'AMICO G,BRENER S J,et al. Survival after varying revascularization strategies in patients with ST-Segment ElevationMyocardial infarction and multivessel coronary artery disease:a pairwise and network Meta-Analysis[J]. JACC Cardiovasc Interv,2016,9(17):1765-1776. 8 JEGER R V,PFISTERER M E. Primary PCI in STEMI - dilemmas and controversies: multivessel disease in STEMI patients. Complete versus Culprit Vessel revascularization in acute ST- elevation myocardial infarction[J]. Minerva Cardioangiol,2011,59(3): 225-233. 9 谢建伟,朱皓,黄榕翀.PCI 术中对比剂剂量与患者血肌酐、肾小球滤过率、肌酐清除率的相关性及对近中期不良事件的影响[J].疑难病杂志,2015,14(4):338-342. 10 赵征,林文华,王晓冬,等.PCI 后新型生物标记物对术中对比剂引起急性肾损伤的预测作用[J].山东医药,2014,54(17):12-14. 11 张小兰.高血清肌酐对急性心肌梗死患者临床治疗效果和预后的影响[J].中国循证心血管医学杂志,2016,8(7):830-832. 12 梁波,苏志荣.高血清肌酐对急性心肌梗死患者治疗效果及预后的影响[J].中西医结合心脑血管病杂志,2014,12(7):892-893. |